Adenosine is a commonly used pharmaceutical stressor at cardiac magnetic resonance examinations to assess suspected chronic coronary syndrome (CCS). However, several studies have reported that the current use of adenosine does not induce adequate hyperemic response in a substantial number of patients, leading to false diagnostics. The aim of this trial is to investigate the hyperemic effect of the standard dose of adenosine (140 microgram/kg/min) to the high dose of adenosine (210 microgram/kg/min) to improve the diagnostic methods using adenosine as a stressor and ultimately improve treatment decisions and patient prognosis in CCS.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
DIAGNOSTIC
Masking
SINGLE
Enrollment
180
Standard dose 140 μg/kg/min and high dose 210 μg/kg/min adenosine
Clinical Physiology, Department of Clinical Sciences Lund, Lund University, Skåne University Hospital
Lund, Sweden
RECRUITINGMyocardial hyperemia
The primary outcome measure is assessed by quantitative myocardial perfusion CMR imaging (ml/min/g).
Time frame: During adenosine infusion, 4-6 minutes
Heart rate response
Compare heart rate (beat/min) at standard and high dose adenosine
Time frame: During adenosine infusion, 4-6 minutes
Blood pressure response
Compare systolic blood pressure (mmHg) at standard and high dose adenosine
Time frame: During adenosine infusion, 4-6 minutes
Symptoms
Compare presence of symptoms (evaluated using a Borg10-scale) at standard and high dose adenosine
Time frame: During adenosine infusion, 4-6 minutes
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.